Helps mitigate the risk for heart disease and dementia that are associated with high LDL levels
By improving LDL levels, helps reduce cardiac and dementia risk for those with no evidence of heart disease
Reduces the risk of recurrent cardiac events in people who have a history of heart disease
Ezetimibe is a cholesterol-lowering medication that works by reducing the absorption of cholesterol in the small intestine. It primarily works on lowering LDL, or “bad” cholesterol, thereby reducing the risk for developing heart disease and coronary events like heart attacks and strokes, as well as reducing the risk for dementia.
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).

Measure your genetic risk for Alzheimer's disease and get ahead of cognitive decline with this advanced blood panel.

Heart attacks and strokes rarely strike at random. Test these key predictors of heart disease.

Reduce the production of “bad” cholesterol in the liver.

Optimize heart, brain, and immune health with broad-spectrum support.